256 related articles for article (PubMed ID: 16249369)
1. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
[TBL] [Abstract][Full Text] [Related]
2. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
[TBL] [Abstract][Full Text] [Related]
3. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
[TBL] [Abstract][Full Text] [Related]
4. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
Loffler M; Bilban M; Reimers M; Waldhäusl W; Stulnig TM
J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
[TBL] [Abstract][Full Text] [Related]
5. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice.
Pannirselvam M; Ding H; Anderson TJ; Triggle CR
Eur J Pharmacol; 2006 Dec; 551(1-3):98-107. PubMed ID: 17027963
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
[TBL] [Abstract][Full Text] [Related]
8. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice.
Lam TY; Seto SW; Lau YM; Au LS; Kwan YW; Ngai SM; Tsui KW
Eur J Pharmacol; 2006 Sep; 546(1-3):134-41. PubMed ID: 16904102
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
Minoura H; Takeshita S; Ita M; Hirosumi J; Mabuchi M; Kawamura I; Nakajima S; Nakayama O; Kayakiri H; Oku T; Ohkubo-Suzuki A; Fukagawa M; Kojo H; Hanioka K; Yamasaki N; Imoto T; Kobayashi Y; Mutoh S
Eur J Pharmacol; 2004 Jun; 494(2-3):273-81. PubMed ID: 15212984
[TBL] [Abstract][Full Text] [Related]
11. Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature.
Ellis A; Cheng ZJ; Li Y; Jiang YF; Yang J; Pannirselvam M; Ding H; Hollenberg MD; Triggle CR
Eur J Pharmacol; 2008 Dec; 601(1-3):111-7. PubMed ID: 18996368
[TBL] [Abstract][Full Text] [Related]
12. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
13. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability.
Pannirselvam M; Verma S; Anderson TJ; Triggle CR
Br J Pharmacol; 2002 May; 136(2):255-63. PubMed ID: 12010774
[TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
[TBL] [Abstract][Full Text] [Related]
15. Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.
Belmadani S; Palen DI; Gonzalez-Villalobos RA; Boulares HA; Matrougui K
Diabetes; 2008 Jun; 57(6):1629-37. PubMed ID: 18319304
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
Kobayashi T; Matsumoto T; Kamata K
Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
[TBL] [Abstract][Full Text] [Related]
17. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.
Gao X; Belmadani S; Picchi A; Xu X; Potter BJ; Tewari-Singh N; Capobianco S; Chilian WM; Zhang C
Circulation; 2007 Jan; 115(2):245-54. PubMed ID: 17200442
[TBL] [Abstract][Full Text] [Related]
20. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
Duncan ER; Walker SJ; Ezzat VA; Wheatcroft SB; Li JM; Shah AM; Kearney MT
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
